Combined effect of histological findings and diabetes mellitus on liver‐related events in patients with metabolic dysfunction‐associated steatotic liver disease

Documenti analoghi

• Effect of remnant cholesterol on the onset of diabetes mellitus
  di: Teruki Miyake, et al.
  Pubblicazione: (2025)
• Fibrosis‐4 Index as a Robust Long‐Term Predictor of Cancers in Metabolic Dysfunction–Associated Steatotic Liver Disease
  di: Ayumi Kanamoto, et al.
  Pubblicazione: (2026)
• Severe hepatic steatosis promotes increased liver stiffness in the early stages of metabolic dysfunction–associated steatotic liver disease
  di: Takashi Kumada, et al.
  Pubblicazione: (2024)
• Association of liver fibrosis progression with non–liver‐related mortality in metabolic dysfunction‐associated steatotic liver disease
  di: Toshifumi Tada, et al.
  Pubblicazione: (2025)
• Serum adropin is unaltered in adolescents with histology‐confirmed steatotic liver disease
  di: Jordan A. Bays, et al.
  Pubblicazione: (2024)